Library / regulatory-reference
Hungary: National Institute of Pharmacy and Nutrition (OGYEI)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Institute of Pharmacy and Nutrition, known by its Hungarian initials OGYEI, is Hungary's national regulatory authority for medicines and medical devices.
Hungary has a long pharmaceutical tradition with a domestic industry exporting across the region, and the institute's registration, licensing and inspection decisions cover both the domestic market and export-active manufacturers.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and establishments are licensed and inspected by the institute.
Post-market work includes safety monitoring within the European alert network and recalls, with the institute maintaining public registers of authorized products.
Regional and international role
The institute is an active member of the European regulatory network, contributing to shared scientific work.
Its oversight of export-oriented domestic manufacturers gives its inspection certificates relevance beyond Hungary's market.
Using this profile
The institute publishes regulations, registers and alerts in Hungarian, with English material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Hungary illustrates the mid-sized producer member state: European-network regulation over a market with a storied domestic industry.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.